Table 5.
Quality of diabetes care
| Dimension | measures | Overall | HC IVs | Hospitals |
|---|---|---|---|---|
| Foundations | Staff & training | 58.3% | 50% | 75% |
| Basic technologies | 85.7% | 82.1% | 92.9% | |
| Diagnostics | 79.2% | 75% | 87.5% | |
| Essential medicines | 72.2% | 66.7% | 83.4% | |
| Process measures | Blood glucose | 100%(377/377) | 100%(377/377) | 100%(377/377) |
| BP | 100%(377/377) | 100%(377/377) | 100%(377/377) | |
| Cholesterol | 0%(0/377) | 0%(0/377) | 0%(0/377) | |
| Urine Protein | 6.4%(24/377) | 22.2%(24/108) | 0%(0/269) | |
| Eye exam | 9.0%(34/377) | 23.1%(25/108) | 3.4%(9/269) | |
| Foot exam | 8.8%(33/377) | 20.4%(22/108) | 4.1%(11/269) | |
| Outcome measures | Glucose control | 56.8%(214/377) | 57.4%(62/108) | 56.5%(152/269) |
| BP control | 49.3%(186/377) | 62%(67/108) | 44.2%(119/269) | |
| Chronic complications | 84.4%(318/377) | 63.9%(69/108) | 92.6%(249/269) | |
| Eye lesions | 84.9%(270/318) | 60.9%(42/69) | 91.6%(228/249) | |
| Peripheral neuropathy | 77.0%(245/318) | 79.7%(55/69) | 76.3%(190/249) | |
| Foot lesions | 20.8%(66/318) | 4.4%(3/69) | 25.3%(63/249) |